Page last updated: 2024-11-06

frontalin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID10888022
MeSH IDM0059281

Synonyms (15)

Synonym
6,8-dioxabicyclo(3.2.1)octane, 1,5-dimethyl-, (1s)-
6,8-dioxabicyclo(3.2.1)octane, 1,5-dimethyl-
frontalin
28401-39-0
unii-9t71zvb55p
(s)-(-)-frontalin
6,8-dioxabicyclo(3.2.1)octane, 1,5-dimethyl-, (1s,5r)-
9t71zvb55p ,
(-)-(1s,5r)-frontalin
DTXSID9041994
frontalin, (-)-
(1s)-1,5-dimethyl-6,8-dioxabicyclo(3.2.1)octane
(1s,5r)-frontalin
Q27889410
(1s,5r)-1,5-dimethyl-6,8-dioxabicyclo[3.2.1]octane
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (4.35)18.7374
1990's1 (4.35)18.2507
2000's12 (52.17)29.6817
2010's8 (34.78)24.3611
2020's1 (4.35)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (95.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]